Total Payments
$4,584
2023 Payments
$28.47
Companies
10
Transactions
27
Medicare Patients
131
Medicare Billing
$10,719
Payment Breakdown by Category
Travel$2,964 (64.7%)
Food & Beverage$1,591 (34.7%)
Education$28.47 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,964 | 5 | 64.7% |
| Food and Beverage | $1,591 | 21 | 34.7% |
| Education | $28.47 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $2,004 | 4 | $0 (2019) |
| NeuroPace, Inc. | $1,919 | 5 | $0 (2019) |
| Allergan Inc. | $302.06 | 7 | $0 (2018) |
| UCB, Inc. | $128.26 | 1 | $0 (2018) |
| Genentech USA, Inc. | $82.55 | 2 | $0 (2017) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $40.94 | 2 | $0 (2023) |
| Boston Scientific Corporation | $31.87 | 2 | $0 (2019) |
| Amgen Inc. | $30.68 | 2 | $0 (2018) |
| Adamas Pharmaceuticals, Inc. | $22.79 | 1 | $0 (2018) |
| CSL Behring | $21.96 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.47 | 1 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($28.47) |
| 2019 | $3,941 | 10 | LivaNova USA, Inc. ($2,004) |
| 2018 | $519.70 | 13 | Allergan Inc. ($302.06) |
| 2017 | $95.02 | 3 | Genentech USA, Inc. ($82.55) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | Radicava (Drug) | Education | In-kind items and services | $28.47 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 07/01/2019 | Boston Scientific Corporation | GENERAL DBS (Device) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: DBS | ||||||
| 04/07/2019 | NeuroPace, Inc. | RNS System (Device) | Food and Beverage | In-kind items and services | $64.78 | General |
| Category: Epilepsy | ||||||
| 04/06/2019 | NeuroPace, Inc. | RNS System (Device) | Travel and Lodging | In-kind items and services | $870.10 | General |
| Category: Epilepsy | ||||||
| 04/06/2019 | NeuroPace, Inc. | RNS System (Device) | Travel and Lodging | In-kind items and services | $625.04 | General |
| Category: Epilepsy | ||||||
| 04/06/2019 | NeuroPace, Inc. | RNS System (Device) | Food and Beverage | In-kind items and services | $275.08 | General |
| Category: Epilepsy | ||||||
| 04/06/2019 | NeuroPace, Inc. | RNS System (Device) | Food and Beverage | In-kind items and services | $83.80 | General |
| Category: Epilepsy | ||||||
| 03/15/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $937.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/15/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $535.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/15/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $276.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/15/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $255.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $128.26 | General |
| Category: Neurology | ||||||
| 06/25/2018 | Boston Scientific Corporation | GENERAL DBS (Device) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: DBS | ||||||
| 06/07/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Neuroscience | ||||||
| 05/29/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neuroscience | ||||||
| 05/25/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/25/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/25/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/09/2018 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: PD | ||||||
| 04/24/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $143.03 | General |
| 04/23/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $139.33 | General |
| 04/09/2018 | CSL Behring | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 02/13/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/19/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/29/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $66.84 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 60 | 61 | $23,643 | $5,695 |
| 2020 | 2 | 71 | 72 | $26,721 | $5,024 |
Total Patients
131
Total Services
133
Medicare Billing
$10,719
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $8,419 | $1,921 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 21 | $5,081 | $1,564 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 14 | $5,079 | $1,220 | 24.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 12 | 12 | $5,064 | $990.22 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 30 | 31 | $10,947 | $2,362 | 21.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 28 | 28 | $11,899 | $1,795 | 15.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 13 | $3,875 | $866.79 | 22.4% |
About Dr. Jason Polchinski, M.D
Dr. Jason Polchinski, M.D is a Neurology healthcare provider based in Martinsburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1770814923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Polchinski, M.D has received a total of $4,584 in payments from pharmaceutical and medical device companies, with $28.47 received in 2023. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($2,964).
As a Medicare-enrolled provider, Polchinski has provided services to 131 Medicare beneficiaries, totaling 133 services with total Medicare billing of $10,719. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Martinsburg, WV
- Active Since 01/27/2010
- Last Updated 01/25/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1770814923
Products in Payments
- VNS Therapy (Device) $2,004
- RNS System (Device) $1,919
- BOTOX (Biological) $282.36
- Briviact (Drug) $128.26
- Non-Covered Product (Drug) $66.84
- Radicava (Drug) $40.94
- Aimovig (Biological) $30.68
- GOCOVRI (Drug) $22.79
- BOTOX THERAPEUTIC (Biological) $19.70
- GENERAL DBS (Device) $17.92
- OCREVUS (Biological) $15.71
- GENERAL DBS (Device) $13.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.